Podcasts by Trials and PIs with Dr Michael Gibson

Trials and PIs with Dr Michael Gibson

What you need to know about today’s top cardiovascular trials in five minutes flat.  Join Dr C Michael Gibson for brief interviews  with the principal investigators


Further podcasts by theheart.org

Podcast on the topic Wissenschaft

All episodes

Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #16: ANTIPAF with Dr Andreas Goette from 2010-11-05T10:41:39

Dr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial.

Recorded at the ESC conv...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #15: AVERROES with Dr Stuart J Connolly from 2010-11-05T10:41:34

Dr Stuart Connolly (McMaster University, Hamilton, ON) discusses AVERROES: apixaban vs acetylsalicylic acid to prevent strokes.

Recorded at the ESC convention center in Stockholm, Sweden o...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #14: FUTURA OASIS 8 with Dr Sanjit Jolly from 2010-10-25T15:10:09

Dr Sanjit Jolly (McMaster University, Hamilton, ON) discusses FUTURA OASIS 8: a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk pati...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #13: RESPONSE with Dr Ron J Peters from 2010-10-21T15:12:32

Dr Ron J Peters (University of Amsterdam, the Netherlands) discusses RESPONSE: effect of a nurse-coordinated prevention program on cardiovascular risk after an acute coronary syndrome.

Rec...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #12: Double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD with Dr Shinya Goto from 2010-10-18T10:07:28

Dr Shinya Goto (Tokai University, Isehara, Japan) discusses the double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD.

Recorded at the ESC convent...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #11: ART with Dr David P Taggart from 2010-10-14T15:06:21

Dr David P Taggart (John Radcliffe Hospital, Oxford, UK) discusses ART: a randomised trial to compare survival following bilateral vs single internal mammary grafting in coronary revascularization....

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #10: HEBE III with Dr A Voors from 2010-10-12T10:31:49

Dr A Voors (University Medical Center Groningen, the Netherlands) discusses HEBE III: a single dose of erythropoietin in ST-elevation myocardial infarction.

Recorded at the ESC convention ...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #9: PCI: State of the art with Dr Sunil Rao from 2010-10-07T10:42:26

Dr Sunil Rao (Duke University Medical Center, Durham, NC) discusses the state of the art of PCI including information on SAFE PCI for women.

Recorded at the ESC convention center in Stockh...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #8: Bleeding Academic Research Consortium (BARC) with Dr Sunil Rao from 2010-10-04T15:08:54

Dr Sunil Rao (Duke University Medical Center, Durham, NC) discusses Bleeding Academic Research Consortium (BARC).

Recorded at the ESC convention center in Stockholm, Sweden on Monday, Augu...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #7: INNOVATE PCI with Dr Sunil Rao from 2010-10-04T15:05:56

Dr Sunil Rao (Duke University Medical Center, Durham, NC) discusses INNOVATE PCI: a phase 2 safety and efficacy study of PRT060128 (elinogrel), a novel intravenous and oral P2Y12 inhibitor.
Listen

Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #6: ISAR REACT 3A with Dr Gilles Montalescot from 2010-09-30T14:35:28

Dr Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris, France) discusses ISAR-REACT 3A and his thoughts on the right dose of heparin.

Recorded at the ESC convention center in Stockholm, ...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #5: Meta-analysis of new thienopyridines with Dr Gilles Montalescot from 2010-09-23T14:29:24

Dr Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris, France) discusses his meta-analysis of new thienopyridines.

Recorded at the ESC convention center in Stockholm, Sweden on Monday, A...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #4: ATOLL with Dr Gilles Montalescot from 2010-09-20T10:41:44

Dr Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris, France) discusses ATOLL: an international, randomized trial comparing IV enoxaparin with IV unfractionated heparin in primary PCI for ST-ele...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #3: ALPHA OMEGA with Dr Daan Kromhout from 2010-09-17T15:34:36

Dr Daan Kromhout (Wageningen University, the Netherlands) discusses ALPHA OMEGA: the effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients.

Recorded at the ...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #2: PEARL HF with Dr Bertram Pitt from 2010-09-13T14:52:34

Dr Bertram Pitt (University of Michigan, Ann Arbor) discusses PEARL HF: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of R...

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #1: Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19 2 loss of function polymorphism with Dr Laurent Bonell from 2010-08-29T11:02:52

What you need to know about today’s top cardiovascular trials in five minutes flat. Join Dr C Michael Gibson for brief interviews with the principal investigators

Listen
Trials and PIs with Dr Michael Gibson
Trials and PIs with Dr Michael Gibson #1: Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19 2 loss of function polymorphism with Dr Laurent Bonell from 2010-08-29T11:02:52

What you need to know about today’s top cardiovascular trials in five minutes flat. Join Dr C Michael Gibson for brief interviews with the principal investigators

Listen